2019-11-13T13:01:18-06:00 2018-12-31 BDO USA LLP 32125 SOLON ROAD STE 200 SOLON OH 44139 990 2018-01-01 270486705 ALLIANCE FOR REGENERATIVE MEDICINE % THOMAS J DULA ALLI 2024192515 525 SECOND STREET NE WASHINGTON DC 20002 JANET LYNCH LAMBERT CEO 2024192515 2019-11-06 true Jacob Cook P01240455 4402488787 99.13.39.123 34986820193175000005 2019-11-13 P 871DF954D879B60D983E468FEED0967A539A383C A1EEB64FDF6F48C4FCD3E72704208A60224B91BD 2018 2020-04-17 16:48:07Z JANET LYNCH LAMBERT 525 SECOND STREET NE WASHINGTON DC 20002 5089429 false X WWW.ALLIANCERM.ORG X 2009 DC SEE SCHEDULE O 27 27 9 535 0 1580 0 0 4015135 5088103 118 1152 0 174 4015253 5089429 0 0 0 0 0 1149639 0 0 0 3712649 3612928 3712649 4762567 302604 326862 2053280 2877756 1301604 1799563 751676 1078193 X SEE SCHEDULE O false false 1939896 2555340 COMMUNICATIONS, CAPITAL FORMATION, AND OPERATIONS: TO DEVELOP PUBLICATIONS, SOCIAL MEDIA STRATEGIES, AND OTHER MATERIALS THAT WILL EDUCATE THE PUBLIC ABOUT REGENERATIVE MEDICINE. 1262301 2382763 POLICY, ADVOCACY, AND GOVERNMENT RELATIONS: TO PROVIDE MEETINGS AND WORKSHOPS THAT WILL ASSIST MEMBERS WITH GOVERNMENT RELATIONS AND REGULATORY DECISION MAKING. 650821 150000 SCIENCE AND TECHNOLOGY: TO DEVELOP CONSENSUS PRODUCT DEVELOPMENT AND REGULATORY STANDARDS, AND PROVIDE MORE EFFICIENT ACCESS TO INDUSTRY BEST-PRACTICES REGARDING MANUFACTURING AND SCALE-UP. 3853018 false false false true false false false false false true false false false false true true false false false false false false false false false false false false true false false false false false false false false false false false false false false false false true 13 0 true 9 true true true false false false true true false false false X 27 27 false true false false false true false true true false false false true true true false false false false false DC X THOMAS J DULA 7038551301 525 SECOND STREET NE WASHINGTON DC 20002 X RAHUL ARAS TREASURER 0.87 0.0 X X 0 0 0 MARTHA ROOK SECRETARY (UNTIL OCT 2018) 0.96 0.0 X X 0 0 0 ROBERT PRETI CHAIRMAN 1.73 0.0 X X 0 0 0 MATTHEW PATTERSON VICE CHAIRMAN 1.54 0.0 X X 0 0 0 NESSAN BERMINGHAM DIRECTOR (UNTIL JAN 2018) 0.0 0.0 X 0 0 0 FARAZ ALI DIRECTOR 0.06 0.0 X 0 0 0 EDUARDO BRAVO DIRECTOR (UNTIL JUNE 2018) 0.12 0.0 X 0 0 0 FLAGG FLANAGAN DIRECTOR 0.29 0.0 X 0 0 0 USMAN 'OZ' AZAM DIRECTOR 0.17 0.0 X 0 0 0 BOB AZELBY DIRECTOR (UNTIL MAY 2018) 0.06 0.0 X 0 0 0 DEBBIE DEAN DIRECTOR 0.17 0.0 X 0 0 0 DENA LADD DIRECTOR 0.17 0.0 X 0 0 0 RON BARTEK DIRECTOR 0.17 0.0 X 0 0 0 MICHAEL MAY DIRECTOR 0.29 0.0 X 0 0 0 SAMUELE BUTERA DIRECTOR (UNTIL JULY 2018) 0.12 0.0 X 0 0 0 PAUL LAIKIND DIRECTOR 0.17 0.0 X 0 0 0 CLAUDIA ZYLBERBERG DIRECTOR 0.17 0.0 X 0 0 0 ISABELLE RIVIERE DIRECTOR 0.23 0.0 X 0 0 0 PHILIP VANEK DIRECTOR 0.87 0.0 X 0 0 0 AMY BUTLER SECRETARY 0.17 0.0 X 0 0 0 SARAH CREVISTON DIRECTOR (UNTIL JUNE 2018) 0.12 0.0 X 0 0 0 MICHAEL HUNT DIRECTOR 0.29 0.0 X 0 0 0 BRUCE LEVINE DIRECTOR 0.17 0.0 X 0 0 0 BILL LUNDBERG DIRECTOR (UNTIL SEPT 2018) 0.12 0.0 X 0 0 0 KEITH THOMPSON DIRECTOR 0.19 0.0 X 0 0 0 JASON WERTHEIM DIRECTOR 0.29 0.0 X 0 0 0 EMILE NUWAYSIR DIRECTOR 0.17 0.0 X 0 0 0 JEFFREY WALSH DIRECTOR 0.29 0.0 X 0 0 0 SUSAN WASHER DIRECTOR 0.29 0.0 X 0 0 0 ZAMI ABERMAN DIRECTOR 0.17 0.0 X 0 0 0 DONNA SKERRETT DIRECTOR 0.12 0.0 X 0 0 0 SANJAYA SINGH DIRECTOR (AS OF FEB 2018) 0.12 0.0 X 0 0 0 BOB SMITH DIRECTOR (AS OF JAN 2018) 0.12 0.0 X 0 0 0 JOSEPH TARNOWSKI DIRECTOR 0.17 0.0 X 0 0 0 GIL VAN BOKKELEN DIRECTOR 0.23 0.0 X 0 0 0 THOMAS J DULA CHIEF FINANCIAL OFFICER 6.0 0.0 X 66000 0 0 JANET LAMBERT CHIEF EXECUTIVE OFFICER 6.0 0.0 X 362500 0 16050 428500 0 16050 1 false true false HOLLAND KNIGHT LLP PO BOX 864084 ORLANDO FL 328864084 STAFFING SERVICES 478884 ADJUVANT PARTNERS LLC 1340 SMITH AVE SUITE 200 BALTIMORE MD 21209 STAFFING SERVICES 356325 EXPERT SERVICE ADVICE IN HEALTHCA ED VANDERVAERENSTRAAT 30A PO BOX 8 HOEILAART 0 BE 1560 MANAGEMENT SERVICES 112876 FORETHOUGHT ACCESS 37 AVENUE DE LAUSANNE GENEVA 0 SZ management services 115128 4 0 MEMBERSHIP DUES 900099 2705340 2705340 STEM CELL CONFERENCE 900099 1905935 1905935 MEMBERSHIP MEETINGS 900099 216185 216185 REGENMED INVESTOR MEETING 900099 260643 260643 5088103 1152 1152 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MEMBER JOB POSTING INCOME 900099 174 174 174 5089429 5088103 1326 0 0 0 0 378550 258389 120161 0 0 652808 445591 207217 0 22229 15173 7056 0 23742 16206 7536 0 72310 49357 22953 0 362502 300002 62500 0 44384 0 44384 0 62413 31492 30921 0 1058241 1058241 0 0 0 0 226495 173115 53380 0 0 76543 0 76543 0 76631 0 76631 0 0 89012 0 89012 0 48012 41731 6281 0 0 1244099 1244099 0 0 0 0 626 0 626 0 27162 11350 15812 0 STRATEGIC PRIORITY 186810 186810 PROJECT EXPENSE 72627 72627 ARM FOUNDATION 29671 21462 8209 BAD DEBT EXPENSE 7700 7700 4762567 3853018 909549 0 1066528 848139 397085 1478176 0 0 581072 281843 0 0 0 0 0 0 0 0 1276 256109 3130 1437 2319 1693 0 0 0 0 0 0 0 0 5000 11796 2053280 2877756 127067 290398 0 0 1174537 1509165 0 0 0 0 0 0 0 0 0 0 0 0 1301604 1799563 X 751676 1078193 0 0 0 0 751676 1078193 2053280 2877756 326862 -345 X false true X true false false false false 2705340 1058241 -115926 942315 811602 130713 3130 1437 1693 1693 0 0 X 5089084 -345 -345 5089429 5089429 4762567 4762567 4762567 PART X, LINE 2: THE ALLIANCE IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE. INCOME TAXES ON UNRELATED BUSINESS INCOME, IF ANY, ARE PROVIDED AT THE APPLICABLE RATES ON INCOME FOR FINANCIAL REPORTING PURPOSES. THE ALLIANCE HAS ADOPTED THE ACCOUNTING GUIDANCE FOR UNCERTAINTY IN INCOME TAXES. USING THAT GUIDANCE, TAX POSITIONS INITIALLY NEED TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE-LIKELY-THAN-NOT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAX AUTHORITIES. AS THE DECEMBER 31, 2018 AND 2017, THE ALLIANCE HAD NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. THE ALLIANCE'S INCOME TAX FILINGS ARE SUBJECT TO AUDIT BY VARIOUS TAXING AUTHORITIES. IN EVALUATING ITS ACTIVITIES, THE ALLIANCE BELIEVES ITS POSTION ON TAX-EXEMPT STATUS IS CURRENT BASED ON CURRENT FACTS AND CIRCUMSTANCES. THE ALLIANCE HAS ASSESSED THAT THERE ARE NO ACTIVTIES UNRELATED TO ITS PURPOSE AND, THEREFORE, NO TAX IS TO BE RECOGNIZED. IT IS THE POLICY OF THE ALLIANCE TO INCLUDE IN EXPENSES, PENALTIES AND INTEREST ASSESSED BY INCOME TAXING AUTHORITIES. THERE ARE NO PENALITES OR INTEREST FROM TAXING AUTHORITIES INCLUDED IN EXPENSES FOR THE YEAR ENDED DECEMBER 31, 2018 AND 2017. false false false false false false false false false JANET LAMBERT CHIEF EXECUTIVE OFFICER 362500 0 0 0 0 0 11000 0 5050 0 378550 0 0 0 FORM 990, PART I, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART III, LINE 1: THE ALLIANCE FOR REGENERATIVE MEDICINE (ARM) IS THE PREEMINENT GLOBAL ADVOCATE FOR REGENERATIVE AND ADVANCED THERAPIES. ARM FOSTERS RESEARCH, DEVELOPMENT, INVESTMENT AND COMMERCIALIZATION OF TRANSFORMATIONAL TREATMENTS AND CURES FOR PATIENTS WORLDWIDE. BY LEVERAGING THE EXPERTISE OF ITS MEMBERSHIP, ARM EMPOWERS MULTIPLE STAKEHOLDERS TO PROMOTE LEGISLATIVE, REGULATORY AND PUBLIC UNDERSTANDING OF, AND SUPPORT OF, THIS EXPANDING FIELD. FORM 990, PART VI, LINE 3: ADJUVANT PARTNERS, LLC IS ENGAGED TO PROVIDE MANAGEMENT SERVICES FOR ALLIANCE FOR REGENERATIVE MEDICINE. FORM 990, PART VI, LINE 7A: THE GOVERNING BODY IS ELECTED BY THE MEMBERS AT THE ANNUAL MEETING THAT TAKES PLACE IN THE FALL EACH YEAR. FORM 990, PART VI, LINE 11B: THE TREASURER AND FINANCE COMMITTEE REVIEW THE TAX RETURN. FORM 990, PART VI, LINE 12C: THE CONFLICT OF INTEREST POLICY COVERS ANY DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURE IS TO DIRECTORS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS. DISCLOSURES ARE REVIEWED AND MAINTAINED BY THE REMAINING MEMBERS OF THE GOVERNING BOARD OR COMMITTEE. THE GOVERNING BOARD OR COMMITTEE REVIEWS EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF POTENTIAL OR ACTUAL CONFLICTS (PAST, PRESENT, OR FUTURE) ARE IDENTIFIED, THE CHAIR PERSON OF THE GOVERNING BOARD OR COMMITTEE SHALL, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER EXERCISING DUE DILIGENCE, THE GOVERNING BOARD OR COMMITTEE SHALL DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGENOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. THE IDENTIFIED CONFLICTS OF INTEREST AND APPROPRIATE RECUSALS ARE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, LINE 19: THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC.